A major problem in the study of animal models of neurodegenerative disease is the lack of an unambiguous marker to identify dying neurons. A new method, the terminal transferase-mediated dUTP-biotin nick end labeling (TUNEL) technique involves the end labeling of fragmented DNA associated with dying cells with biotinylated nucleotides, after which cells are visualized via avidin-conjugated peroxidase. The method has been used successfully to label cells undergoing programmed death in the digestive, lymphatic, and reproductive systems and skin. TUNEL has not been applied to studies of cell death in the nervous system, and in this Pilot, we propose a series of experiments designed to investigate the validity and usefulness of this technique as a tool to enhance our understanding of neuronal cell death. Initially, we will validate the selectivity and specificity of the technique on tissues from the spinal cord of rats at embryonic day 16, a time point at which naturally occurring motor neuron death has been reported. Subsequently, we will examine three animal models of retrograde neuronal degeneration that are well established in our laboratory, one involving neonatal and the other two involving adult neurons. The studies described in this Pilot will allow us to determine the usefulness of TUNEL in identifying degenerating neurons. This strategy will then be used to investigate these issues in other models, including transgenic mice in our Alzheimer's Disease Research Center (ADRC), and eventually, to focus this approach on processes that lead to death of neurons in the human brain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-14
Application #
5204510
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Shi, Liu; Baird, Alison L; Westwood, Sarah et al. (2018) A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication. J Alzheimers Dis 62:1181-1198
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Na, Chan Hyun; Barbhuiya, Mustafa A; Kim, Min-Sik et al. (2018) Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini. Genome Res 28:25-36
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7
Kaji, Seiji; Maki, Takakuni; Kinoshita, Hisanori et al. (2018) Pathological Endogenous ?-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System Atrophy. Stem Cell Reports 10:356-365
Oh, Esther S; Blennow, Kaj; Bigelow, George E et al. (2018) Abnormal CSF amyloid-?42 and tau levels in hip fracture patients without dementia. PLoS One 13:e0204695
Johnson, Erik C B; Dammer, Eric B; Duong, Duc M et al. (2018) Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13:52
Albert, Marilyn; Zhu, Yuxin; Moghekar, Abhay et al. (2018) Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain :

Showing the most recent 10 out of 830 publications